Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network.
![PEAR-TREE: Understanding the usefulness of the PEAR-BIO platform in patients with kidney cancer](http://media.springernature.com/w100/bmc-blogs/on-medicine/wp-content/uploads/sites/6/2024/01/2024-01-05-13_37_18-Window-125x125.png)
Now you’ve identified a journal to submit to, there are a few things you should be familiar with before you submit.
To give your manuscript the best chance of publication, follow these policies and formatting guidelines.
After acceptance, we provide support so your article gains maximum impact in the scientific community and beyond.
Please note that manuscript can only be submitted by an author of the manuscript and may not be submitted by a third party.
Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network.
2022 Citation Impact
28.5 - 2-year Impact Factor
23.1 - 5-year Impact Factor
4.045 - SNIP (Source Normalized Impact per Paper)
6.046 - SJR (SCImago Journal Rank)
2023 Speed
5 days submission to first editorial decision for all manuscripts (Median)
59 days submission to accept (Median)
2023 Usage
3,173,795 downloads
2,671 Altmetric mentions
06 April 2023
Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).